FHTX
FHTX
NASDAQ · Biotechnology

Foghorn Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks
$4.15
+0.10 (+2.47%)
Analyst Consensus
Strong Buy
16
Analysts
High
Coverage
Buy 15 94%
Hold 1 6%
Sell 0 0%
Price Target
Analyst Price Target +598.6% upside
Low Target $18.54
Average Target $28.99
High Target $38.99
Current Price $4.15
Current
$4.15
Target
$28.99
$18.54 $28.99 avg $38.99
Scenario Analysis
Bear Case
$18.54
346.7%
Low target
Base Case
$28.99
+598.6%
Avg target
Bull Case
$38.99
+839.5%
High target
Risk/Reward
2.4x
Favorable
Price in Context
52-Week High
$6.95
-40.3% from high
52-Week Low
$3.27
+26.9% from low
Target vs 52W High
$28.99
+317.1% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 78% $257.58 +9.6%
AMGN
Amgen Inc
 Hold 44 50% $190.87 -45.9%
GILD
Gilead Sciences Inc
 Strong Buy 39 82% $362.68 +190.0%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -6.4%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -87.6%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 37 76% $102.31 -64.5%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -32.7%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -39.1%